Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, (Q41964667)
Jump to navigation
Jump to search
scientific article published on 18 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, |
scientific article published on 18 February 2014 |
Statements
1 reference
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin compared with α-glucosidase inhibitor in Japanese patients with type 2 diabetes inadequately controlled on sulfonylurea alone (SUCCESS-2): a multicenter, randomized, open-label, (English)
1 reference
K Kobayashi
1 reference
H Yokoh
1 reference
Y Sato
1 reference
M Takemoto
1 reference
D Uchida
1 reference
A Kanatsuka
1 reference
N Kuribayashi
1 reference
T Terano
1 reference
N Hashimoto
1 reference
K Sakurai
1 reference
H Hanaoka
1 reference
K Ishikawa
1 reference
S Onishi
1 reference
K Yokote
1 reference
SUCCESS Study Group
1 reference
18 February 2014
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference